MEREDITH FOX: Open Payments
NPI 1730437732 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 43 payments from 12 companies in 2025. Trend: 2023 $456 · 2024 $289 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $160 |
| Y-mAbs Therapeutics, Inc. | 1 | $103 |
| Corcept Therapeutics | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Lilly USA, LLC | 4 | $64 |
| Novo Nordisk Inc | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Dexcom, Inc. | 2 | $35 |
| Eisai Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, DANYELZA, Korlym, AIRSUPRA, MOUNJARO, QULIPTA, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across CT — which companies pay providers there.
